Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Albert Bourla

Donald Trump undermines his one lonely success that is apparently his one-way ticket to the Nobel Peace Prize

Looks like he is running out of things to destroy.

We Got This Covered

Pfizer CEO is latest to say Trump should get Nobel Peace Prize – for something much of MAGA hates

Vaccine makers are publicly defending Covid-era achievements as the Trump administration rolls back vaccine approvals and cuts research funding

The Independent UK

‘We will work collaboratively’: Big Pharma admits it is discussing Trump’s plan to lower drug prices

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer options

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer posts strong earnings despite Trump’s new 'up to 250%' tariff threat

Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.

Euronews

EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports

The New York Times reports that text messages between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely been destroyed

The Independent UK

The EU and Africa, Newsletter

This week's key events presented by Euronews' editor in chief of EU news Jeremy Fleming-Jones.

Euronews

European court delivers blow to EU Commission over Von der Leyen-Pfizer texts

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

Radio France Internationale

Read news from The Economist, FT, and more,
with one subscription

How the love story between von der Leyen and Pfizer turned sour

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story between Ursula von der Leyen and big pharma Pfizer.

Euronews

Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

The Guardian - UK

Judgment Day In EU Chief's Covid Vaccine Texts Case

A top court is to rule Wednesday on whether the EU failed the transparency test by declining to release text messages sent by Ursula von der Leyen to the head of Pfizer as the bloc tried to secure Covid vaccines.

International Business Times

Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research

Also: 90% of earnings calls mention tariffs, China says there are no talks with Washington on trade.

Fortune

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Latin Times

Pfizer CEO Booed At White House Event

President Trump's praise of Pfizer CEO at Black History Month event sparks mixed audience reactions due to company's Covid-19 vaccine controversy.

Top News

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

Investors Business Daily

Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now

Pfizer stock bounded off its 50-day line on Monday after avoiding a battle with activist investor Starboard Value — for now.

Barchart

This Dividend Stock Has Plunged Ahead of Trump’s Inauguration. Here Are 3 Reasons Investors Should Still Buy It.

For savvy investors, Pfizer could be an undervalued stock to buy here.

The Guardian - UK

Eighty years after thousands of Greek Jews were murdered, Thessaloniki’s Holocaust museum is finally set to open

Germany is among donors committing millions to the long-awaited project, to be completed in 2026, which will tell story of those who perished

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Why Pfizer Stock Is Lower After a Beat-and-Raise Quarter

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

The Guardian - UK

Gold price hits fresh record high, as bitcoin also rallies – as it happened

Analysts say gold is benefited from safe-haven demand amid persistent geopolitical tensions, expectations of monetary policy easing, and mounting uncertainty surrounding the US presidential election.

Fortune

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

Pfizer is getting back on track—but an even more potent prescription for success could be in the cards for the pharmaceutical giant under.

Investors Business Daily

Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises

Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.

Barchart

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

Investors Business Daily

Pfizer Skids After Former Execs Flip On Starboard; Activist Investor Says They Were Coerced

Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.

Fortune

Pfizer stock surges after activist takes $1 billion stake

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

1,117 stories

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.